
MED-EL is an Austrian-based, family-owned business that offers the widest range of implantable & non-implantable solutions to treat all degrees of hearing loss, enabling recipients in 117 countries to achieve successful hearing outcomes.
MED-EL have led the industry in researching and designing new innovative hearing technologies, including the latest BONEBRIDGE BCI 602 and the MED-EL Synchrony Cochlear Implant, which has over 5 years proven 3.0T MRI safety without magnet removal.
Our comprehensive hearing solution portfolio includes cochlear and middle ear implant systems, a combined Electric Acoustic Stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices.
MED-EL have led the industry in researching and designing new innovative hearing technologies, including the latest BONEBRIDGE BCI 602 and the MED-EL Synchrony Cochlear Implant, which has over 5 years proven 3.0T MRI safety without magnet removal.
Our comprehensive hearing solution portfolio includes cochlear and middle ear implant systems, a combined Electric Acoustic Stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices.
Contact Person: Katie Evans
+64 9 415 9555 ~ katie.evans@medel.com ~ www.medel.com
Suite 2.07, 90-96 Bourke Road, Alexandra, NSW 2015, Australia
+64 9 415 9555 ~ katie.evans@medel.com ~ www.medel.com
Suite 2.07, 90-96 Bourke Road, Alexandra, NSW 2015, Australia